Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 35 (HMGN1P35) is a human genomic locus classified as a pseudogene and does not encode a functional protein. Pseudogenes are DNA sequences similar to known genes but typically lack protein-coding capability due to disruptive mutations or absence of regulatory elements[1][2]. While some pseudogenes in other families can regulate their parent gene's expression through non-coding RNA mechanisms—such as competitive endogenous RNAs (ceRNAs) or small inhibitory RNAs—in the case of HMGN1P35, there are presently no reports of transcriptional activity, biological function, disease association, or pharmacological relevance[1][2][3][4]. Thus, HMGN1P35 is not recognized as a molecular target, therapeutic receptor, or biomarker.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 35 (HMGN1P35).